You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Avatrombopag,Primary Immune Thrombocytopenia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia(ITP)

Recruiting
  • Primary Immune Thrombocytopenia
  • Jinan, Shandong, China
    Qilu Hospital, Shandong University
Jun 24, 2021

Immune Thrombocytopenia Trial in Japan (Avatrombopag Oral Tablet)

Recruiting
  • Immune Thrombocytopenia
  • Avatrombopag Oral Tablet
  • Toyohashi, Aichi, Japan
  • +18 more
Jan 11, 2023

A Study of Switching Avatrombopag and Rh-TPO in ITP

Not yet recruiting
  • Corticosteroid-resistant or Relapsed ITP
    • (no location specified)
    May 29, 2021

    Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • Obinutuzumab Injection [Gazyva]
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Oct 17, 2023

    Immune Thrombocytopenia, Autoantibodies, Evan Syndrome Trial in Tianjin (Avatrombopag)

    Recruiting
    • Immune Thrombocytopenia
    • +3 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Aug 3, 2021

    ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • hetrombopag 5mg po qd
    • High-dose Dexamethasone
    • (no location specified)
    Jul 5, 2023

    Immune Thrombocytopenia Trial (Avatrombopag 20 mg Oral Tablet)

    Withdrawn
    • Immune Thrombocytopenia
    • Avatrombopag 20 mg Oral Tablet
    • (no location specified)
    Oct 15, 2021

    Pediatric Primary Immune Thrombocytopenia (ITP)

    Recruiting
    • Primary Immune Thrombocytopenia
    • data collection
    • Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Oct 31, 2023

    Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • Obinutuzumab Injection [Gazyva]
    • Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Aug 9, 2023

    Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)

    Completed
    • Primary Immune Thrombocytopenia
    • Shandong, China
      Qilu Hospital of Shandong University
    Nov 20, 2022

    Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)

    Recruiting
    • Immune Thrombocytopenia Purpura
    • Cairo, Egypt
      EL-Kasr elineiy
    May 6, 2023

    Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Ianalumab
    • (no location specified)
    Jun 5, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)

    Recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Ianalumab
    • +2 more
    • Singapore, Singapore
      Novartis Investigative Site
    Jan 17, 2023

    Immune Thrombocytopenia Trial (Herombopag)

    Not yet recruiting
    • Immune Thrombocytopenia
    • (no location specified)
    Jan 13, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Tianjin (TPO-RAs, TPO-RAs combining anti-CD 20 mAb)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • TPO-RAs
    • TPO-RAs combining anti-CD 20 monoclonal antibody
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Feb 7, 2023

    Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)

    Not yet recruiting
    • Chronic Primary Immune Thrombocytopenia (ITP)
    • Bengbu, Anhui, China
    • +13 more
    Aug 15, 2023

    Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)

    Recruiting
    • Primary Immune Thrombocytopenia
    • Ianalumab
    • +2 more
    • Singapore, Singapore
      Novartis Investigative Site
    Jan 23, 2023

    Avatrombopag for Thrombocytopenia in Patients Undergoing

    Recruiting
    • Thrombocytopenia
    • Shanghai, China
      Zhongshan hospital, Fudan University
    Oct 9, 2021

    Immune Thrombocytopenia Trial in United States (Avatrombopag Oral Tablet)

    Recruiting
    • Immune Thrombocytopenia
    • Avatrombopag Oral Tablet
    • Tucson, Arizona
    • +13 more
    Jul 1, 2022

    Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • CM313 Injection
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Jan 12, 2023

    Immune Thrombocytopenia Trial (Daratumumab Injection)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Daratumumab Injection
    • (no location specified)
    Sep 28, 2022

    Primary Immune Thrombocytopenia Trial in Spain (Romiplostim plus dexamethasone, Dexamethasone)

    Recruiting
    • Primary Immune Thrombocytopenia
    • Barcelona, Spain
    • +14 more
    Dec 22, 2022

    Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Beijing, Beijing, China
      Peking University Insititute of Hematology, Peking University Pe
    Jul 14, 2022

    Immune Thrombocytopenia Trial in Sohag (Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR
    • Sohag, Egypt
      Sohag University Hospital
    Jul 19, 2022

    Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)

    Recruiting
    • Immune Thrombocytopenia
    • +3 more
    • potential biomarkers
    • Graz, Styria, Austria
      Pediatric Hematology-Oncology Outpatient Clinic
    Sep 8, 2022